Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | STAT1 | P42224 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29549932 | 1.00 | GRM4 (0.44) | GRM4KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL5704392 | 0.90 | ALDH1A1 (0.42) | GRM4KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL9577110 | 0.88 | PTK2B (0.44) | GRM4HPGDKMT2AMAPTMEN1 | |
| SCHEMBL9064777 | 0.88 | GRM4 (0.38) | GRM4KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL6255840 | 0.88 | PTK2B (0.44) | GRM4HPGDKMT2AMAPTMEN1 | |
| SCHEMBL26667034 | 0.87 | HSD17B10 (0.59) | GRM4KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL11013322 | 0.87 | LMNA (0.42) | GRM4KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL6959141 | 0.84 | GRM4 (0.43) | GRM4KDM4EHPGDKMT2ARAB9A | |
| SCHEMBL57100 | 0.84 | KMT2A (0.44) | GRM4KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL1638840 | 0.83 | ALDH1A1 (0.40) | GRM4KDM4EHPGDHSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 996 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572728-B1 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | MOUNTAIN VIEW PHARMACEUTICALS (US) | 2014-06-25 | — | — | EP | claimed |
| US-20120114742-A1 | Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2012-05-10 | — | — | US | claimed |
| US-8129330-B2 | Complex of polyoxyethylene glycol with active material | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2012-03-06 | — | — | US | claimed |
| JP-2006510601-A | — | — | 2006-03-30 | — | — | JP | claimed |
| EP-1572728-A2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | Mountain View Pharmaceuticals, Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| EP-1421175-A4 | POLYMER STABILIZED PROTEINASES | MOUNTAIN VIEW PHARMACEUTICALS (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1421175-A2 | POLYMER STABILIZED PROTEINASES | Mountain View Pharmaceuticals, Inc. (US) | 2004-05-26 | — | — | EP | claimed |
| WO-2004030617-A2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2004-04-15 | — | — | WO | claimed |
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2004-04-01 | — | — | US | claimed |
| US-20030012777-A1 | Polymer conjugates of proteinases | MOUNTAIN VIEW PHARMACEUTICALS, INC. | 2003-01-16 | — | — | US | claimed |
| WO-2003002716-A2 | POLYMER STABILIZED PROTEINASES | MOUNTAIN VIEW PHARMACEUTICALS, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| CN-122095024-A | Flame-retardant aromatic polycarbonate resin composition and molded article thereof | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026100296-A1 | FLAME-RETARDANT AROMATIC POLYCARBONATE RESIN MASTER BATCH AND METHOD FOR MANUFACTURING SAME | 信越化学工業株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260001986-A1 | THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING | MCE TECHNICAL CENTER B V (NL) | 2026-01-01 | — | — | US | disclosed |
| EP-4551652-A1 | THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING | MCE Technical Center B.V. (NL) | 2025-05-14 | — | — | EP | disclosed |
| US-4001175-A | ADDITIVES OF METAL SALTS OF SULFONIC ACIDS OF AROMATIC SULFOXIDES | GENERAL ELECTRIC COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3971756-A | SILOXANE, ORGANIC ALKALI OR ALKALINE EARTH SALTS | GENERAL ELECTRIC COMPANY (US) | 1976-07-27 | — | — | US | disclosed |
| US-3945967-A | ALKYL PHOSPHITE, EPOXY COMPOUND | GENERAL ELECTRIC COMPANY (US) | 1976-03-23 | — | — | US | disclosed |
| US-3933730-A | POLYDIMETHYLSILOXANE GUM, DIVIDED SILICA | GENERAL ELECTRIC COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040062748-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | GRM4 3760/4885KDM4E 1796/4885HPGD 2377/4885 |
| US-20040062746-A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | CD14, HLA-C, HLA-A | GRM4 3760/4885KDM4E 1796/4885HPGD 2377/4885 |
| US-20260001986-A1 | THERMOPLASTIC COMPOSITION FOR LASER DIRECT STRUCTURING | DYNLL2, PUM2, DYNLL1 | GRM4 477/4885KDM4E 1855/4885HPGD 4803/4885 |
| US-20120114742-A1 | Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof | CD14, HLA-C, HLA-A | GRM4 3760/4885KDM4E 1796/4885HPGD 2377/4885 |
| US-20030012777-A1 | Polymer conjugates of proteinases | PRNP, PRSS3, PRSS1 | GRM4 3590/4885KDM4E 2259/4885HPGD 1919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.